Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma

AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NIS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical pathology 1992-05, Vol.45 (5), p.382-384
Hauptverfasser: Cooper, K, Herrington, C S, Lo, E S, Evans, M F, McGee, J O
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 384
container_issue 5
container_start_page 382
container_title Journal of clinical pathology
container_volume 45
creator Cooper, K
Herrington, C S
Lo, E S
Evans, M F
McGee, J O
description AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 on archival biopsy specimens using digoxigenin labelled probes. RESULTS: A total of 20 adenocarcinomas (53%) from both groups contained HPV DNA. In the UK group, seven and four cases contained HPV 18 (44%) and 16 (25%) respectively. In the South African group, nine cases contained HPV 18 (41%) while HPV DNA was not detectable in the other 13 cases. Hence HPV 18 was present in 80% of HPV positive adenocarcinomas. CONCLUSIONS: The HPV 16 or 18 genome was integrated in all viral positive cases. In two cases HPV 18 was also present in an episomal form. These data indicate that HPV integration is common to cervical adenocarcinoma in two continents by the same methodology. The lower prevalence of HPV 18 detection in the South African group may have been due to the presence of other or unsequenced HPV types.
doi_str_mv 10.1136/jcp.45.5.382
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_495296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3971356101</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4512-e2436a38eba88c011cd04d0df89ac778709bb94b636f09999802eaaee31436853</originalsourceid><addsrcrecordid>eNqFkb2P1DAQxSMEOpaDjhYpEggasnhsJ7YLCrTHx0mnpQFaa-I4d14SJ2cnK-6_x9Gulo8C3Lh4v_c0My_LngJZA7Dqzc6Ma16uyzWT9F62Ai5owYFX97MVIRQKJXj1MHsU444QYALYWXYGDISUbJVtL_1krwNObvD50OY3c48-H3F0XTf0uHdhjvl0N9qYQ5Wjb3KQufO5sWHvDHY5NtYPBoNxPvGPswctdtE-Of7n2dcP779sPhVXnz9ebt5dFTUvgRaWclYhk7ZGKQ0BMA3hDWlaqdAIIQVRda14XbGqJSo9SahFtJZBMsqSnWdvD7njXPe2MdZPATs9BtdjuNMDOv2n4t2Nvh72mquSqir5Xx79YbidbZx076KxXYfeDnPUgioBUoj_glApKihfEp__Be6GOfh0BA1CEF4SUS1xrw-UCUOMwbankYHopU2d2tS81KVObSb82e9r_oIP9SX9xVHHmMpoA3rj4gnjTEJJl5jigLk42R8nGcN3nWYSpd5-2-gLQi-2W6X0ct1XB77ud_8e8Cco_sJG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770450767</pqid></control><display><type>article</type><title>Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cooper, K ; Herrington, C S ; Lo, E S ; Evans, M F ; McGee, J O</creator><creatorcontrib>Cooper, K ; Herrington, C S ; Lo, E S ; Evans, M F ; McGee, J O</creatorcontrib><description>AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 on archival biopsy specimens using digoxigenin labelled probes. RESULTS: A total of 20 adenocarcinomas (53%) from both groups contained HPV DNA. In the UK group, seven and four cases contained HPV 18 (44%) and 16 (25%) respectively. In the South African group, nine cases contained HPV 18 (41%) while HPV DNA was not detectable in the other 13 cases. Hence HPV 18 was present in 80% of HPV positive adenocarcinomas. CONCLUSIONS: The HPV 16 or 18 genome was integrated in all viral positive cases. In two cases HPV 18 was also present in an episomal form. These data indicate that HPV integration is common to cervical adenocarcinoma in two continents by the same methodology. The lower prevalence of HPV 18 detection in the South African group may have been due to the presence of other or unsequenced HPV types.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.45.5.382</identifier><identifier>PMID: 1317883</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Adenocarcinoma - microbiology ; Adenocarcinoma - pathology ; Biological and medical sciences ; DNA Probes, HPV ; DNA, Viral - analysis ; Female ; Female genital diseases ; Genome, Viral ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Nucleic Acid Hybridization ; Papillomaviridae - classification ; Papillomaviridae - genetics ; Papillomaviridae - isolation &amp; purification ; Uterine Cervical Neoplasms - microbiology ; Uterine Cervical Neoplasms - pathology</subject><ispartof>Journal of clinical pathology, 1992-05, Vol.45 (5), p.382-384</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD May 1992</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4512-e2436a38eba88c011cd04d0df89ac778709bb94b636f09999802eaaee31436853</citedby><cites>FETCH-LOGICAL-b4512-e2436a38eba88c011cd04d0df89ac778709bb94b636f09999802eaaee31436853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC495296/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC495296/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4381522$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1317883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cooper, K</creatorcontrib><creatorcontrib>Herrington, C S</creatorcontrib><creatorcontrib>Lo, E S</creatorcontrib><creatorcontrib>Evans, M F</creatorcontrib><creatorcontrib>McGee, J O</creatorcontrib><title>Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 on archival biopsy specimens using digoxigenin labelled probes. RESULTS: A total of 20 adenocarcinomas (53%) from both groups contained HPV DNA. In the UK group, seven and four cases contained HPV 18 (44%) and 16 (25%) respectively. In the South African group, nine cases contained HPV 18 (41%) while HPV DNA was not detectable in the other 13 cases. Hence HPV 18 was present in 80% of HPV positive adenocarcinomas. CONCLUSIONS: The HPV 16 or 18 genome was integrated in all viral positive cases. In two cases HPV 18 was also present in an episomal form. These data indicate that HPV integration is common to cervical adenocarcinoma in two continents by the same methodology. The lower prevalence of HPV 18 detection in the South African group may have been due to the presence of other or unsequenced HPV types.</description><subject>Adenocarcinoma - microbiology</subject><subject>Adenocarcinoma - pathology</subject><subject>Biological and medical sciences</subject><subject>DNA Probes, HPV</subject><subject>DNA, Viral - analysis</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genome, Viral</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Nucleic Acid Hybridization</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - isolation &amp; purification</subject><subject>Uterine Cervical Neoplasms - microbiology</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkb2P1DAQxSMEOpaDjhYpEggasnhsJ7YLCrTHx0mnpQFaa-I4d14SJ2cnK-6_x9Gulo8C3Lh4v_c0My_LngJZA7Dqzc6Ma16uyzWT9F62Ai5owYFX97MVIRQKJXj1MHsU444QYALYWXYGDISUbJVtL_1krwNObvD50OY3c48-H3F0XTf0uHdhjvl0N9qYQ5Wjb3KQufO5sWHvDHY5NtYPBoNxPvGPswctdtE-Of7n2dcP779sPhVXnz9ebt5dFTUvgRaWclYhk7ZGKQ0BMA3hDWlaqdAIIQVRda14XbGqJSo9SahFtJZBMsqSnWdvD7njXPe2MdZPATs9BtdjuNMDOv2n4t2Nvh72mquSqir5Xx79YbidbZx076KxXYfeDnPUgioBUoj_glApKihfEp__Be6GOfh0BA1CEF4SUS1xrw-UCUOMwbankYHopU2d2tS81KVObSb82e9r_oIP9SX9xVHHmMpoA3rj4gnjTEJJl5jigLk42R8nGcN3nWYSpd5-2-gLQi-2W6X0ct1XB77ud_8e8Cco_sJG</recordid><startdate>19920501</startdate><enddate>19920501</enddate><creator>Cooper, K</creator><creator>Herrington, C S</creator><creator>Lo, E S</creator><creator>Evans, M F</creator><creator>McGee, J O</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19920501</creationdate><title>Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma</title><author>Cooper, K ; Herrington, C S ; Lo, E S ; Evans, M F ; McGee, J O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4512-e2436a38eba88c011cd04d0df89ac778709bb94b636f09999802eaaee31436853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adenocarcinoma - microbiology</topic><topic>Adenocarcinoma - pathology</topic><topic>Biological and medical sciences</topic><topic>DNA Probes, HPV</topic><topic>DNA, Viral - analysis</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genome, Viral</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Nucleic Acid Hybridization</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - isolation &amp; purification</topic><topic>Uterine Cervical Neoplasms - microbiology</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cooper, K</creatorcontrib><creatorcontrib>Herrington, C S</creatorcontrib><creatorcontrib>Lo, E S</creatorcontrib><creatorcontrib>Evans, M F</creatorcontrib><creatorcontrib>McGee, J O</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cooper, K</au><au>Herrington, C S</au><au>Lo, E S</au><au>Evans, M F</au><au>McGee, J O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>1992-05-01</date><risdate>1992</risdate><volume>45</volume><issue>5</issue><spage>382</spage><epage>384</epage><pages>382-384</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 on archival biopsy specimens using digoxigenin labelled probes. RESULTS: A total of 20 adenocarcinomas (53%) from both groups contained HPV DNA. In the UK group, seven and four cases contained HPV 18 (44%) and 16 (25%) respectively. In the South African group, nine cases contained HPV 18 (41%) while HPV DNA was not detectable in the other 13 cases. Hence HPV 18 was present in 80% of HPV positive adenocarcinomas. CONCLUSIONS: The HPV 16 or 18 genome was integrated in all viral positive cases. In two cases HPV 18 was also present in an episomal form. These data indicate that HPV integration is common to cervical adenocarcinoma in two continents by the same methodology. The lower prevalence of HPV 18 detection in the South African group may have been due to the presence of other or unsequenced HPV types.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>1317883</pmid><doi>10.1136/jcp.45.5.382</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9746
ispartof Journal of clinical pathology, 1992-05, Vol.45 (5), p.382-384
issn 0021-9746
1472-4146
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_495296
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adenocarcinoma - microbiology
Adenocarcinoma - pathology
Biological and medical sciences
DNA Probes, HPV
DNA, Viral - analysis
Female
Female genital diseases
Genome, Viral
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Nucleic Acid Hybridization
Papillomaviridae - classification
Papillomaviridae - genetics
Papillomaviridae - isolation & purification
Uterine Cervical Neoplasms - microbiology
Uterine Cervical Neoplasms - pathology
title Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A49%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integration%20of%20human%20papillomavirus%20types%2016%20and%2018%20in%20cervical%20adenocarcinoma&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=Cooper,%20K&rft.date=1992-05-01&rft.volume=45&rft.issue=5&rft.spage=382&rft.epage=384&rft.pages=382-384&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.45.5.382&rft_dat=%3Cproquest_pubme%3E3971356101%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770450767&rft_id=info:pmid/1317883&rfr_iscdi=true